Skip to main content

Table 1 Demographic characteristics of varying stages of chronic kidney disease

From: Urinary cell-free mitochondrial and nuclear deoxyribonucleic acid correlates with the prognosis of chronic kidney diseases

Variables

Stage 1,2a

Stage 3Ab

Stage 3Bc

Stage 4,5d

p value

Post hoc

 

n = 23

n = 28

n = 31

n = 42

  

Age (year)

47.1 ± 12.7

53.6 ± 9.4

54.9 ± 10.5

58.7 ± 6.1

0.002*

a < c,d

Gender (M/F)

3/20

8/20

22/9

29/13

0.212

 

Hypertension (%)

42%

37%

59%

54%

0.191

 

Diabetes mellitus (%)

12%

11%

23%

54%

0.160

 

Systolic blood pressure (mm Hg)

138 ± 18

144 ± 28

138 ± 24

142 ± 15

0.943

 

Diastolic blood pressure (mm Hg)

90 ± 15

91 ± 4

84 ± 18

84 ± 12

0.784

 

BMI (kg/m2)

27.8 ± 5.4

28.2 ± 6.1

26.2 ± 6.1

24.8 ± 4.3

0.172

 

BUN (mg/dL)

14.3 ± 4.4

17.7 ± 3.8

31.4 ± 13.0

64.5 ± 27.1

<0.001**

a,b < c < d

eGFR (ml/min/1.73 m^2)

84.4 ± 20.2

52.1 ± 4.4

31 ± 9.6

11.5 ± 7.3

<0.001**

a > b > c > d

Phosphate (mg/dL)

3.5 ± 0.4

3.5 ± 0.6

4.0 ± 0.7

5.0 ± 1.1

<0.001**

a,b,c < d

Cholesterol (mg/dL)

198.3 ± 50.4

171.5 ± 31.8

196.6 ± 47.3

153.3 ± 44.5

0.001**

a,c > d

HDL-C (mg/dL)

47.8 ± 14.3

43.3 ± 9.8

46.1 ± 12.6

46.7 ± 21.2

0.677

 

LDL-C (mg/dL)

118.2 ± 45.3

104.6 ± 31.4

114.9 ± 41.3

80.8 ± 26.7

0.040*

c > d

Fasting Glucose (mg/dL)

118.3 ± 46.1

106 ± 21.8

112.6 ± 43.5

94.9 ± 24.6

0.263

 

HbA1C (%)

6.3 ± 1.4

6.0 ± 0.6

6.2 ± 1.1

6.1 ± 0.9

0.778

 

Urine A/C ratio (mg/g)

438.0 ± 826.4

535.7 ± 1018.4

2121.3 ± 2540.7

1548.0 ± 2377.2

0.058

 

WBC (×103/μL)

7.1 ± 2.4

6.2 ± 1.9

6.4 ± 2.1

6.8 ± 2.0

0.323

 

Uric Acid (mg/dL)

7.1 ± 1.2

7.0 ± 1.4

7.5 ± 2.6

7.0 ± 1.2

0.629

 

Platelet(×103/μL)

230.2 ± 72.6

209.2 ± 59.5

201.9 ± 51.1

195.1 ± 58.2

0.159

 
  1. P-value by One-Way ANOVA follow with Bonferroni multiple comparisons at type I error of 0.05 level
  2. *P <0.05, **P <0.01. Gender (M/F), female/male; BMI, body mass index; BUN, blood urea nitrogen; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HbA1C, glycated hemoglobin; WBC, white blood count; eGFR, estimated glomerular filtration rate; urine A/C ratio, urine albumin-creatinine ratio
  3. Post hoc: aindicates group stage 1,2; bindicates group stage 3a; cindicates group stage 3b; dindicates group stage 4,5